These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 18287589

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs.
    Scheiman JM.
    Gastroenterol Clin North Am; 2009 Jun; 38(2):305-14. PubMed ID: 19446260
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Update on nonsteriodal anti-inflammatory drugs.
    Ardoin SP, Sundy JS.
    Curr Opin Rheumatol; 2006 May; 18(3):221-6. PubMed ID: 16582683
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs.
    Jones R, Rubin G, Berenbaum F, Scheiman J.
    Am J Med; 2008 Jun; 121(6):464-74. PubMed ID: 18501223
    [Abstract] [Full Text] [Related]

  • 29. Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction.
    Andersohn F, Suissa S, Garbe E.
    Circulation; 2006 Apr 25; 113(16):1950-7. PubMed ID: 16618816
    [Abstract] [Full Text] [Related]

  • 30. Cardiovascular risks of cyclooxygenase inhibition.
    Stacy ZA, Dobesh PP, Trujillo TC.
    Pharmacotherapy; 2006 Jul 25; 26(7):919-38. PubMed ID: 16803424
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The risk of acute myocardial infarction with etodolac is not increased compared to naproxen: a historical cohort analysis of a generic COX-2 selective inhibitor.
    Warner JJ, Weideman RA, Kelly KC, Brilakis ES, Banerjee S, Cunningham F, Harford WV, Kazi S, Little BB, Cryer B.
    J Cardiovasc Pharmacol Ther; 2008 Dec 25; 13(4):252-60. PubMed ID: 18787084
    [Abstract] [Full Text] [Related]

  • 33. Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.
    Dajani EZ, Islam K.
    J Physiol Pharmacol; 2008 Aug 25; 59 Suppl 2():117-33. PubMed ID: 18812633
    [Abstract] [Full Text] [Related]

  • 34. Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis.
    Becker MC, Wang TH, Wisniewski L, Wolski K, Libby P, Lüscher TF, Borer JS, Mascette AM, Husni ME, Solomon DH, Graham DY, Yeomans ND, Krum H, Ruschitzka F, Lincoff AM, Nissen SE, PRECISION Investigators.
    Am Heart J; 2009 Apr 25; 157(4):606-12. PubMed ID: 19332185
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Cardiovascular safety of non-steroidal anti-inflammatory drugs among healthy individuals.
    Fosbøl EL, Køber L, Torp-Pedersen C, Gislason GH.
    Expert Opin Drug Saf; 2010 Nov 25; 9(6):893-903. PubMed ID: 20569079
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib.
    Farkouh ME, Greenberg JD, Jeger RV, Ramanathan K, Verheugt FW, Chesebro JH, Kirshner H, Hochman JS, Lay CL, Ruland S, Mellein B, Matchaba PT, Fuster V, Abramson SB.
    Ann Rheum Dis; 2007 Jun 25; 66(6):764-70. PubMed ID: 17412741
    [Abstract] [Full Text] [Related]

  • 39. Use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs in high doses increases mortality and risk of reinfarction in patients with prior myocardial infarction.
    Sørensen R, Abildstrom SZ, Torp-Pedersen C, Gislason GH.
    J Cardiovasc Nurs; 2008 Jun 25; 23(1):14-9. PubMed ID: 18158501
    [Abstract] [Full Text] [Related]

  • 40. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk.
    Woodruff T.
    Intern Med J; 2006 Dec 25; 36(12):797-8; author reply 798-9. PubMed ID: 17096747
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.